Back to top

Image: Bigstock

GENOCEA BIOSCIENCES (GNCA) Catches Eye: Stock Gains 7.1%

Read MoreHide Full Article

GENOCEA BIOSCIENCES, INC. was a big mover last session, as its shares rose over 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up over 19% in the past one-month time frame.

None of the estimates for this stock were revised over the past 30 days. The Zacks Consensus Estimate also remained unchanged over the same time frame. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

GENOCEA BIOSCIENCES currently carries a Zacks Rank #3 (Hold), while its Earnings ESP is 0.00%.

A better-ranked stock in the Medical - Drugs space is Grifols, S.A. (GRFS - Free Report) , sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is GNCA going up? Or down? Predict to see what others think: Up or Down
   
Will You Make a Fortune on the Shift to Electric Cars?

Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.

With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.

It's not the one you think.

See This Ticker Free >>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Grifols, S.A. (GRFS) - free report >>

Published in